Product Information
HYDROCODONE-CHLORPHEN ER SUSP is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.4775 per ML under NDC 27808008601. Its NADAC has been published 573 times since Oct 14, 2015.
FDA first approved this application on Oct 1, 2010.
Strength
8; 10 mg/5mL; mg/5mL
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808008601
Classification
Generic
Dosage Form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091632FDA Approved
10/1/2010
On Market Since
3/6/2015
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-CHLORPHEN ER SUSP has been published 573 times since Oct 14, 2015, and over the history we have for it it has risen 10.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4775 per ML |
|---|---|
| All-time high | $0.4829 (Jun 10, 2026) |
| All-time low | $0.3215 (May 22, 2024) |
| 52-week high | $0.4829 |
| 52-week low | $0.4693 |
| Median price | $0.4355 |
| Average price | $0.4275 |
| Largest weekly change | +28.1% (Feb 22, 2023) |
| Weeks tracked | 573 |
| Tracking since | Oct 14, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cranbury Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Polistirex and Chlorpheniramine Polistirex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE-CHLORPHEN ER SUSP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-CHLORPHEN ER SUSP, manufactured by Cranbury Pharmaceuticals, LLC, is $0.4775 per ML (NDC 27808008601), effective Sep 30, 2026.
How has the price of HYDROCODONE-CHLORPHEN ER SUSP changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-CHLORPHEN ER SUSP has risen 10.0%. It has been tracked across 573 weekly CMS publications since Oct 14, 2015.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-CHLORPHEN ER SUSP?
Since Oct 14, 2015, the NADAC for HYDROCODONE-CHLORPHEN ER SUSP has ranged from a low of $0.3215 (May 22, 2024) to a high of $0.4829 (Jun 10, 2026), with a median of $0.4355 per ML.
Are there cheaper alternatives to HYDROCODONE-CHLORPHEN ER SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROCODONE-CHLORPHEN ER SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROCODONE-CHLORPHEN ER SUSP?
HYDROCODONE-CHLORPHEN ER SUSP (NDC 27808008601) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.